Eli Gilboa, Professor of Microbiology & Immunology, University of Miami, to present at 7th Non-Coding RNA & RNAi Therapeutics Conference
Online PR News – 27-July-2016 – Boston, MA – Eli Gilboa, Professor of Microbiology & Immunology at the University of Miami, will give a presentation on “Oligonucleotide Aptamer Targeted RNA Therapeutics: A Novel Platform for Cancer Immunotherapy” at GTCbio’s 7th Coding RNA & RNAi Therapeutics Conference to be held on September 14-15, 2016 in Boston, MA.
Professor Gilboa is currently focusing his research on multi-pronged approaches to cancer immunotherapy using nucleic acid-based drug and drug delivery platforms. In his presentation, he will describe the use of complementary and synergistic strategies to potentiate antitumor immunity in cancer patients using oligonucleotide aptamer platforms to target immune modulatory siRNAs or aptamers to the immune system or the tumor microenvironment, respectively.
The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues in the RNA research field. Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. Advances in cell selective delivery and the target abilities of RNAi demonstrate growth and maturity in the field. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings. This will include stability, affinity and specificity of oligonucleotide aptamer ligands and other delivery approaches as well.
This meeting will create space for researchers to learn about the latest discoveries in the field, as well as share and discuss perspectives during networking sessions.
The 7th Coding RNA & RNAi Therapeutics Conference consists of the following sessions:
Session topics include:
I. CRISPR Mediated Genome Editing and Functional Screening
II. Emerging Applications for Non-Coding RNA
III. Therapeutic Delivery of Nucleic Acid-Based Drugs
IV. Advances in RNAi, Antisense, and Non-Coding RNA-Based Drugs in Clinical Development
For more information, please visit website: https://www.gtcbio.com/conferences/non-coding-rna-rnai-therapeutics-overview
635 W. Foothill Blvd
Monrovia, CA 91016
Phone: (626) 256-6405
Fax: (626) 466-4433